ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,028 | -63.1% | 56,244 | -72.7% | 1.04% | -62.9% |
| Q1 2023 | $8,195 | -43.6% | 206,328 | -42.9% | 2.80% | -45.0% |
| Q4 2022 | $14,541 | -99.9% | 361,447 | -1.6% | 5.09% | +6.5% |
| Q3 2022 | $11,806,000 | +8.2% | 367,326 | -0.1% | 4.78% | +17.2% |
| Q2 2022 | $10,911,000 | +18.4% | 367,754 | +12.1% | 4.08% | +25.8% |
| Q1 2022 | $9,218,000 | -39.1% | 327,929 | -0.2% | 3.24% | -31.4% |
| Q4 2021 | $15,137,000 | +38.2% | 328,494 | -1.6% | 4.72% | +30.0% |
| Q3 2021 | $10,952,000 | +30.7% | 333,686 | +39.6% | 3.63% | +23.8% |
| Q2 2021 | $8,380,000 | +5.4% | 239,101 | +8.7% | 2.93% | -1.2% |
| Q1 2021 | $7,949,000 | +70.2% | 219,962 | +36.8% | 2.97% | +58.0% |
| Q4 2020 | $4,670,000 | – | 160,796 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |